Chemung Financial Corporation Announces Approval of New Stock Repurchase Program
ELMIRA, N.Y., March 18, 2020 (GLOBE NEWSWIRE) — Chemung Financial Corporation (the “Corporation”) (NASDAQ: CHMG), the parent company of Chemung […]
Liquidity Services Auctioning Tier 2 and Tier 3 Drilling and Well Service Equipment on Its Newest Online Auction Marketplace, AllSurplus
BETHESDA, Md., March 18, 2020 (GLOBE NEWSWIRE) — Liquidity Services (NASDAQ: LQDT), a global solution provider in the reverse supply […]
CarGurus Supports Dealers with Billings Discount
CAMBRIDGE, Mass., March 18, 2020 (GLOBE NEWSWIRE) — Today CarGurus issued the following letter to shareholders.Dear Shareholder,As we evaluate the […]
ACM Research Launches Stress-Free Polishing Tool for Advanced Packaging Applications; Delivers First Tool to Leading Chinese OSAT
FREMONT, Calif., March 18, 2020 (GLOBE NEWSWIRE) — ACM Research, Inc. (NASDAQ: ACMR), a leading supplier of wafer processing solutions […]
TSX News -
CONDOR ANNOUNCES 2019 YEAR END RESULTS
CALGARY, Alberta, March 18, 2020 (GLOBE NEWSWIRE) — Condor Petroleum Inc. (“Condor” or the “Company”) (TSX: CPI), a Canadian based […]
ACM Research Reports Fourth Quarter and Fiscal Year 2019 Results
FREMONT, Calif., March 18, 2020 (GLOBE NEWSWIRE) — ACM Research, Inc. (“ACM” or the “Company”) (NASDAQ:ACMR), a leading supplier of […]
Acer Receives Formal Dispute Resolution Request (FDRR) Response from FDA’s Office of New Drugs
NEWTON, Mass., March 18, 2020 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, […]
89bio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
– BIO89-100 Phase 1b/2a NASH study on track for topline data in 2H20 –– Initiation of Phase 2 SHTG study […]
One Medical Announces Results for Fourth Quarter and Full Year 2019
Fourth Quarter 2019 Net Revenue of $77.4 Million, a 33% Increase Year-Over-YearFull Year 2019 Net Revenue of $276.3 Million, a […]
Osmotica Pharmaceuticals plc Reports Fourth Quarter and Full Year 2019 Results and Provides Business Updates
Fourth quarter and full year 2019 total revenue of $59.9 million and $240.0 million, respectivelyNew Drug Application accepted by FDA […]
